InvestorsHub Logo
Followers 15
Posts 1146
Boards Moderated 0
Alias Born 04/12/2014

Re: Musical Shares post# 95862

Thursday, 11/04/2021 10:27:05 PM

Thursday, November 04, 2021 10:27:05 PM

Post# of 118387
The question is, how often do you change your mind? I have seen you often do that.

Why?

You wrote followings on 10/29/21.

———————————


Quote:

I would advise against drinking the Koos Aid.



While I think the phrase "Koos Aid" is clever, I would have to say that the "I would advise against drinking" part not so much.

What your missing is the understanding of the actual NR2F6 patent document as a whole.

Then, taking it a step further by cross referencing peer reviewed papers and surrounding science of that particular science.

There is a science on how to write a patent. That's why finding a patent attorney who is capable of such is incredibly important.

Okay, so know your asking yourself, what is the point this person is getting at...

Look over Regen's patents for NR2F6.. Do you see anything that stands out?

That's right... the patents are INCREDIBLY BROAD in scope. The patent attorney and Regen clearly understood how to cover a wide area of intellectual property for this science.

Now you must be asking yourself, then why all these years couldn't anything get done about it?

Because the concept of NR2F6 is an ALTERNATIVE immune checkpoint. It is and was never fully understood nor considered as a "promising" technology. There are two other immune checkpoints that are better suited and were more "promising" (CTLA-4 and PD-1).

Do you know why it is called an Orphan Nuclear Receptor? Because it has no known ligand... something that is crucial with drug ability.

It's coming... and the quest for working with NR2F6 is an ambitious goal for many scientist's around the world... :)

Dr. Koos is not a failure here. Slightly before his time. But not a failure just yet.

Cheerio.